Alice Valder Curran
Partner
Washington, D.C.
340B Program: HRSA Releases Proposed “Omnibus” or “Mega” Guidance, Which Lives Up To Its Name
28 August 2015
Health, Pharmaceutical, and Biotechnology AlertThe Health Resources and Services Administration (HRSA) yesterday released its “340B Drug Pricing Program Omnibus Guidance,” also known as the “Mega-Guidance,” in proposed form.
Read more: 340B Program: HRSA Releases Proposed “Omnibus” or “Mega” Guidance, Which Lives Up To Its Name
Contacts
Ken Choe
Partner
Washington, D.C.
Christopher H. Schott
Partner
Washington, D.C.
